At Hotel President in Novi Sad, in front of more than 70 participants – physicians of different specialties from Novi Sad and all other Vojvodina cities, a professional meeting was held at which the Vemax Pharma company presented the therapeutic possibilities of the product Selitop®.

This product with a selenium dose of 200 mcg (L-selenmethionine) is widely used, especially in treatments of thyroid diseases. Eminent experts – endocrinologists and ophthalmologists from the Clinical Center of Vojvodina delivered lectures on the following topics:

1. Autoimmune thyroid disease – professor Ljiljana Todorović-Đilas, MD
2. The palce of L-selenmethionine in clinical thyroidology – assistant professor Ivana Bajkin, MD
3. Effect of L-selenmethionine on other endocrinopathies – Bojan Vuković, MD
4. Clinical application of L-selenmethionine in thyroid disease – assistant professor Tijana Ičin, MD
5. Administration of L-selemethionine in patients with Graves orbitopathy – Sava Barišić, MD

A sovereign, guide-confirmed advantage of L-selenmethionine as an organic form of selenium over non-organic forms of selenium is highlighted. This is true for patients with hypothyroidism, but also for those with hypothyroidism and Graves orbitopathy.

In Hotel 88 Rooms in Belgrade, in front of more than 80 participants – physicians of different specialties from Belgrade, Valjevo, Šabac, Kragujevac, and Loznica, a professional meeting was held at which the the Vemax Pharma company presented the therapeutic possibilities of the product Selitop®.

This product with a selenium dose of 200 mcg (L-selenmethionine) is widely used, especially in treatments of thyroid diseases. Eminent experts – endocrinologists and ophthalmologists from the Clinical Center of Serbia – delivered lectures on the following topics:

1. Selenium and oxidative stress – professor Miloš Žarković, MD, the Clinical Center of Serbia
2. Clinical administration of L-selenmethionine in patients with hypothyroidism – assistant professor Biljana Beleslin, MD, the Clinical Center of Serbia
3. Clinical administration of L-selenmethionine in patients with hyperthyroidism – professor Jasmina Ćirić, MD, the Clinical Center of Serbia
4. Administration of L-selenmethionine in Graves orbitopathy – clinical approach from an ophthalmologist’s standpoint – professor Miroslav Knežević, MD, the Clinical Center of Serbia

A sovereign, guide-confirmed advantage of L-selenmethionine as an organic form of selenium over non-organic forms of selenium is highlighted. This is true for patients with hypothyroidism, but also for those with hypothyroidism and Graves orbitopathy.

The meeting of the Neurosurgical Section of the Serbian Medical Society, organized by the Clinic for Neurosurgery of the Clinical Center of Niš, was held at the Nais Hotel on December 7th, 2019.

The topic of this conference was: The DSG system – limitations and possibilities of neurosurgery.

The Vemax Pharma company arranged a showroom self-presentation for the participants of the Section and a symposium on the contemporary therapeutic possibilities in the treatment of neuropathies – with an emphasis on the products Neuronal and Combinerv.

As part the section’s official program, the neurosurgeons from the Clinical Center of Niš – the Clinic for Neurosurgery covered the following topics:

1. Neuronal® – clinical use in patients with nerve injuries and compressive neuropathies – Professor Ivan Stefanović, MD
2. Combinerv® – an innovative quadruple combination in the treatment of peripheral neuropathies – Radisav Mitić, MD

The Vemax Pharma company was one of the sponsors of the First Congress of Kosovo and Metohija Physicians held in Kosovska Mitrovica between 29 November and 1 December 2019.

As part of the official section of this Congress, a Symposium was held on the following topics:

1. Synosteo®, Arthronal® – new therapeutic options in the treatment of osteoporosis and osteoarthritis – Zlatica Petković-Mirković, MD, the Medical Faculty of Kosovska Mitrovica
2. Neuronal®, Combinerv® – new therapeutic options in the treatment of neuropathies – Vladimir Krstić, MD, Vemax Pharma

In addition to the academic aspect of participating in this event, we proudly emphasize the fact that we were the only pharmaceutical company that actively participated in the work of the Congress and supported the efforts of colleagues from Kosovo and Metohija who, despite difficult living and working conditions, managed to organize the event attended by more than 500 physicians of various specialties.

The XII/XVIII National Congress organized by the Society of Serbian Neurologists was held in Vrnjačka Banja between 28 November and 1 December 2019.

The Vemax Pharma company arranged a showroom self-presentation for the professional public from the country and the region and a symposium on contemporary therapeutic options in the treatment of neuropathies – with an emphasis on the Neuronal and Combinerv products.

At the expert symposium, eminent lecturers from the Clinical Center of Vojvodina addressed the following topics:

1. Combinerv® – innovative quadruple combination as a pain treatment support – Dr. Svetlana Simić, professor, the Clinical Center of Vojvodina – Neurology Clinic
2. Neuronal® – clinical application in patients with compressive neuropathies and nerve injuries – Dr. Zita Jovin, the Clinical Center of Vojvodina – Neurology Clinic

Organized by the Diabetes Association of Serbia and the Diabetes Board of the Serbian Medical Society, with the support from the Faculty of Medicine in Belgrade, the Serbian Academy of Arts and Sciences and other professional associations, the 11th Serbian Congress on Diabetes with international participation was held in Belgrade between 24 and 27 November 2019. The congress brought together more than 500 physicians from the country and the region, including the most prominent speakers on diabetes and comorbidity in patients with diabetes.

The Vemax Pharma company arranged a showroom self-presentation at which, among other things, we presented preliminary affirmative mini-study results in the clinical application of Combinerv® in patients with diabetic polineuropathy, and of Cardiovasc plus® in the treatment of hyperlipidemia and hypercholesterolemia in patients with metabolic syndrome.

The aforementioned mini-studies were conducted at the Clinic for Endocrinology, Diabetes and Metabolism Diseases of the Clinical Center of Serbia, under the direction of prof. dr. Aleksandra Jotić and prof. dr. Katarina Lalić.

The Annual Congress of the Serbian Neurosurgical Society, held in Kragujevac between 25th and 27th October 2019, was a unique opportunity to introduce the Vemax Pharma company to neurosurgeons from Serbia, Montenegro, Macedonia, and Bosnia and Herzegovina, as well as numerous participants from other countries from Europe and worldwide.

In addition to the showroom where we presented the entire range of our products, within the official program of the Congress our company also held a mini-symposium on the following topic:
Novel emerging therapeutic supplements in the treatment of neurovascular disorders; augmentation biases in regeneration and sanation of oxidative stress. Myth or reality?

Porfessor Lukas Rasulić, the president of the Serbian Neurosurgical Society, the president of the Eastern Europe Neurosurgical Society and the chairman of the EANS 2020 Congress, presented in a highly expert manner new therapeutic options for neurosurgical patients: Neuronal®, Combinerv® and Cardiovasc plus®.

Organized by the multidisciplinary Association for Menopause and Involuntary Hypoandrogenism, the Serbian Association for Gender Endocrinology, the Endocrinology Section of the Serbian Medical Society, the Faculty of Medicine in Belgrade, the Clinic for Endocrinology, Diabetes and Metabolism of the Clinical Center of Serbia, with the following topic: THE APPROACH TO IMPROVING THE QUALITY OF LIFE IN MIDDLE AGE.

The Vemax Pharma company arranged a self-presentation showroom for the professional public from the country and the region.

The emphasis in communication with the congress participants was primarily on Synosteo®, which stands out by its composition and therapeutic use in patients with osteoporosis, osteopenia, post-fracture conditions, or in support of a healthy bone metabolism. Also, we had the opportunity to introduce a wide portfolio of products intended for internal medicine and endocrinological patients: Selitop®, Cardiovasc plus®, Combinerv® and New Iron®.

The sixth Master Class multidisciplinary gathering of more than 500 participants from the country and the region was held in Belgrade from 4 to 5 October 2020. This year’s edition of the Master Class focused on the topic of pain in patients with osteoporosis and osteoarthritis

The Vemax Pharma company arranged a showroom self-presentation for the professional public from the country and the region.

The emphasis in communication with congress participants was primarily put on the Synosteo® product, which stands out with its composition and therapeutic use in patients with osteoporosis, osteopenia, post-fracture conditions, or in support of healthy bone metabolism, but also in presenting the benefits of other products, such as Neuronal®, Combinerv® and Arthronal®, which are related to the profile of this conference.

A national Psychoneuroimmunology congress, a multidisciplinary expert meeting, was held between 26th and 29th September 2019 in Niš (The Niš Fortress Summer Stage/Hotel New City).

The Vemax Pharma company arranged a showroom self-presentation for the professional public from the country and the region and a symposium on contemporary therapeutic options in the treatment of neuropathies – with an emphasis on the Neuronal and Combinerv products.

At the expert symposium, the leading experts from the Clinical Center of Niš‚ discussed the following topics:

1. The neuroprotective role of ALA in stroke – professor Miroslava Živković, MD, Director of the Neurology Clinic, the Clinical Center of Niš
2. Combinerv® – an innovative quadruple combination in the treatment of diabetic polyneuropathy – professor Gordana Đorđević, MD, Head of the Department for Neuromuscular Diseases, the Clinical Center of Niš
3. Neuronal® – a clinical application in patients with compressive neuropathies and nerve injuries –  assistant professor Srđan Ljubisavljević, MD, Head of the CVO and Pain Therapy Department, the Clinical Center of Niš